Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | hypothetical protein, conserved | 0.2105 | 1 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.1004 | 0.1906 | 0.1906 |
Schistosoma mansoni | hypothetical protein | 0.1423 | 0.4982 | 0.4982 |
Brugia malayi | Kringle domain containing protein | 0.2105 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.2105 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1423 | 0.4982 | 0.4262 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.2105 | 1 | 0.5 |
Toxoplasma gondii | kringle domain-containing protein | 0.2105 | 1 | 0.5 |
Onchocerca volvulus | 0.2105 | 1 | 1 | |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.2105 | 1 | 0.5 |
Loa Loa (eye worm) | DOMON domain-containing protein | 0.1423 | 0.4982 | 0.4262 |
Loa Loa (eye worm) | hypothetical protein | 0.2105 | 1 | 1 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.2105 | 1 | 1 |
Brugia malayi | Muscle positioning protein 4 | 0.1597 | 0.6261 | 0.2548 |
Schistosoma mansoni | hypothetical protein | 0.2105 | 1 | 1 |
Echinococcus granulosus | tissue type plasminogen activator | 0.2105 | 1 | 0.5 |
Onchocerca volvulus | 0.1597 | 0.6261 | 0.2548 | |
Loa Loa (eye worm) | hypothetical protein | 0.1597 | 0.6261 | 0.5724 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.2105 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 300 uM | Inhibitory activity against Oxidosqualene-lanosterol cyclase in pig liver | ChEMBL. | 2769687 |
IC50 (binding) | = 300 uM | Inhibitory activity against Oxidosqualene-lanosterol cyclase in pig liver | ChEMBL. | 2769687 |
IC50 (binding) | > 400 uM | Inhibitory activity against Squalene Epoxidase in pig liver | ChEMBL. | 2769687 |
IC50 (binding) | > 400 uM | Inhibitory activity against Squalene Epoxidase in pig liver | ChEMBL. | 2769687 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.